Menu Content
How may we help?
I am a new caregiver
I need information
I need a laugh
Home arrow News arrow Articles

Register
Why Register?

Login

Chat

CHAT NOW
There are chat connections.
There are logon users.
There are chat rooms.
Chatting users:

Calendar

March 2010 > »
M T W T F S S
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31 1 2 3 4
News
Damaged Protein Identified as Early Diagnostic Biomarker for Alzheimer's Disease in Health Adults
Thursday, 25 February 2010

Researchers at NYU School of Medicine have found that elevated cerebrospinal fluid levels of phosphorylated tau231 (P-tau231), a damaged tau protein found in patients with Alzheimer’s disease, may be an early diagnostic biomarker for Alzheimer’s disease in healthy adults. 

The study, published this month online by Neurobiology of Aging, shows that high levels of P-tau231 predict future memory decline and loss of brain gray matter in the medial temporal lobe—a key memory center. Prior studies found the medial temporal lobe to be the most vulnerable brain region in the early stages of Alzheimer’s disease, accumulating damaged tau proteins in the form of neurofibrillary tangles. Tangles are one of the signature indicators of Alzheimer’s disease, in addition to beta amyloid plaques.  

“Our research results show for the first time that elevated levels of P-tau 231 in normal individuals can predict memory decline and accompanying brain atrophy,” said lead author Lidia Glodzik MD, PhD, assistant research professor, Department of Psychiatry at the Center for Brain Health and Center of Excellence on Brain Aging at NYU School of Medicine. “Our findings suggest that P-tau231 has the potential to be an important diagnostic tool in the pre-symptomatic stages of Alzheimer’s disease.”  

Researchers evaluated 57 cognitively healthy older adults and studied the relationships between baseline cerebrospinal fluid biomarkers, longitudinal memory performance and longitudinal measures of the medial temporal lobe gray matter using magnetic resonance imaging, or MRI. Two years later, researchers found that 20 out of 57 healthy adults showed decreased memory performance. The group with worsened memory had higher baseline levels of P-tau231 and more atrophy in the medial temporal lobe. The higher P-tau231 levels were associated with reductions in medial temporal lobe gray matter. Authors concluded that elevated P-tau231 predicts both memory decline and medial temporal lobe atrophy. 

“Indentifying people at risk for Alzheimer’s disease is the necessary first step in developing preventive therapies,” said co-author Mony de Leon, EdD, professor, Department of Psychiatry, and director of the Center for Brain Health at the Center of Excellence on Brain Aging at NYU School of Medicine and research scientist at the Nathan S. Kline Institute for Psychiatric Research. “This study shows that Alzheimer’s disease pathology may be recognized in the normal stages of cognition. This observation may be of value in future studies investigating mechanisms that cause or accelerate dementia.”  

This study was done in collaboration with the Nathan S. Kline Institute for Psychiatric Research (NY), Applied NeuroSolutions, Inc. (IL), QiLu Hospital of Shandong University (China), The Sahlgrenska Academy at University of Gothenburg and Sahlgrenska University Hospital (Sweden) and the Institute for Basic Research (NY).  

Funding for this study was provided by the National Institutes of Health (NIH) in Bethesda, Maryland.

 
Social Security Administration Adds Early-Onset Alzheimer's To Compassionate Allowance Initiative
Thursday, 11 February 2010
Washington, DC February 11, 2010 – In its effort to improve and expedite the disabilitydetermination process, the Social Security Administration (SSA) has announced that itwill add early-onset Alzheimer’s disease to its Compassionate Allowances Initiative. Theinitiative identifies debilitating diseases and medical conditions that meet the SSA’sdisability standards for Social Security Disability Income (SSDI) or SupplementalSecurity Income (SSI). Inclusion in the initiative allows for faster payment of SocialSecurity benefits to individuals with Alzheimer’s disease. The Alzheimer’s Associationapplauds Social Security Commissioner Michael Astrue and the SSA for understandingthat the cognitive impairment caused by Alzheimer’s disease leaves individuals unableto maintain gainful employment and deserving of an expedited disability determination. “As the leading research, advocacy, and support organization for Alzheimer’s disease,the Alzheimer’s Association has actively sought the inclusion of early-onset Alzheimer’sin the Social Security Administration’s Compassionate Allowances Initiative,” says HarryJohns, President and CEO of the Alzheimer’s Association. “Now, individuals who aredealing with the enormous challenges of Alzheimer’s won’t also have to endure thefinancial and emotional toll of a long disability decision process.” Since 2003, the Alzheimer’s Association has been advocating on behalf of individualswith early-onset Alzheimer’s as they navigate the Social Security disabilitydeterminations process and welcomes the SSA’s decision. Until now, individuals withearly-onset Alzheimer’s disease have faced a myriad of challenges when applying forSSDI or SSI, including a long decision process, initial denials, and multiple appeals.Today’s decision will simplify and streamline the SSDI/SSI application process anddecrease the wait time for benefits, which for some has lasted as long as three years. There are currently an estimated 5.3 million Americans with Alzheimer’s disease.Although the majority of Alzheimer cases are individuals age 65 and older, a significantnumber of people under age 65 are also affected by this fatal disease and have fewfinancial options other than the Social Security disability program. In addition to Alzheimer’s disease, mixed-dementia and Primary Progressive Aphasiawere also added to the Compassionate Allowances Initiative under the SSA’s recentdecision. To determine which diseases and conditions to include, SSA has held severalpublic outreach hearings throughout the country that have included testimony frommedical and scientific experts, as well as those directly affected by these diseases andconditions. The July 2009 Compassionate Allowance Hearing on Early-OnsetAlzheimer’s Disease and Related Dementias, held in Chicago, included testimony fromJohns, several of the nation’s top Alzheimer researchers, and caregivers and individualswith early-onset Alzheimer’s who discussed the challenges they faced during thedisability application process. During the day-long hearing, SSA officials heard about theterminal nature of Alzheimer’s, the disabilities that often prohibit work in even the earlieststages of the disease, and the lack of effective treatments to modify or halt theprogression of Alzheimer’s. In addition to participation in the hearing, as many as 600 people with Alzheimer’s andother dementias and their caregivers responded to the Association’s request to submitwritten comments to SSA about their experiences applying for disability benefits. Asample of these comments are posted on SSA’s Compassionate Allowances website:http://www.socialsecurity.gov/compassionateallowances/statements.htm The Social Security Administration’s proactive efforts to “fast track” certain conditions willhelp to reduce the backlog of disability claims and, more importantly, ensure thoseclaims that fall under this initiative will be decided within days instead of months oryears. “The diagnosis of Alzheimer’s indicates significant enough cognitive impairment tointerfere with daily living activities, including the ability to work. This decision will help asignificant number of Alzheimer families. It will also help the Social SecurityAdministration, since long delays and appeals in the disability determination process arecostly for the agency,” says Johns. “The Alzheimer’s Association praises SSA for thisdecision and remains committed to continue to work with Commissioner Astrue and hiscolleagues at the Social Security Administration in support of its implementationnationwide.” Alzheimer’s AssociationThe Alzheimer's Association is the leading voluntary health organization in Alzheimer care,support and research. Our mission is to eliminate Alzheimer’s disease through the advancementof research; to provide and enhance care and support for all affected; and to reduce the risk ofdementia through the promotion of brain health. Our vision is a world without Alzheimer’s. Formore information, visit www.alz.org.
 
ARE YOU READY FOR LIFE THE 20-PART PBS SERIES THAT HELPS BOOMERS PREPARE FOR LIFE’S SECOND ACT
Wednesday, 20 January 2010
Second Season of Twin Cities Public Television-Produced Series, Hosted by Award-Winning Journalist Robert Lipsyte, Premieres September 13, 2009 (check local listings)Joy Behar, David Hyde Pierce, Martha Stewart, Gov. Mike Huckabee, Billie Jean King Are Among Guests That Share Their Perspectives on Life After 50They are 78 million strong, and as they hit their 50’s and 60’s, they are still a generational phenomenon, changing the way we as a country perceive growing older. Baby boomers are pushing traditional limits, like they always have, but this time, they are redefining ageing and everything associated with it. This new “old age” is the focus of the groundbreaking 20-part PBS series Life (Part 2), hosted by former New York Times columnist and Emmy Award-winner Robert Lipsyte. Launching its second season in the fall of 2009 (check local listings), Life (Part 2), produced by Twin Cities Public Television, celebrates the boomer generation’s fresh approach to aging. They are fitter, will live longer, will look better, will earn more, and will be more active than any generation before them. But are they ready for Life (Part 2)? Offering lively conversation from an eclectic mix of writers, thinkers, performers, and ordinary people, the series provokes, entertains, and educates boomers on how they can overcome the societal, physical and financial obstacles that come with aging to live a vibrant and fulfilling second part. Major funding for Life (Part 2) is provided by The Atlantic Philanthropies and MetLife Foundation.With wit, insight, and the experience of having made the passage himself, Lipsyte engages in candid dialogue with a wide range of guests from “boomer” celebrities like Joy Behar, Martha Stewart, Phil Donahue, Gail Sheehy, David Hyde Pierce, Billie Jean King, and Governor Mike Huckabee to such experts as former Ms. editor Suzanne Braun Levine (Fifty is the New Fifty: Ten Life Lessons for Women in Second Adulthood), Harvard professor Sara Lawrence-Lightfoot (The Third Chapter: Passion Risk and Adventure in the 25 Years After 50) and President of Yankelovich, J. Walker Smith (Generation Ageless). Offering their own amusing take in video essays are Barney’s Creative Director, Simon Doonan, Former New York District Attorney and author Linda Fairstein, author Maureen Orth, legendary editor Sir Harry Evans, among others... all of whom have one thing in common: they’re getting older and they refuse to accept the clichés that come with the territory.MetLife Foundation is pleased to support this PBS series that will help older Americans prepare for and enjoy the next phase in their lives," says Dennis White, president & CEO of MetLife Foundation. "The Life (Part 2) series provides an important voice and platform to discuss the pressing issues facing aging adults." The Atlantic Philanthropies are also dedicated to bringing about lasting changes in the lives of disadvantaged and vulnerable people. Atlantic focuses on four critical social problems: Aging, Children & Youth, Population Health, and Reconciliation & Human Rights.Says series host Robert Lipsyte, “Life (Part 2) is not necessarily better or worse than Part 1, but it is different. The series offers a tremendous amount of wisdom from a wide range of experts and fellow boomers to support you as you enter into Part 2… to make you brave!”    Each week, Life (Part 2) tackles one of the many questions on the minds of baby boomers as they approach this latest stage of their journey. How can they overcome ageism and experience a financially secure second act... whether in retirement or in a new career? How do they balance their own financial needs with those of their grown children and aging parents? What are the secrets to relationships that last through the decades and what are the challenges facing newly single baby boomers when they start to date again? Can plastic surgery and eliminating the “boomer belly” renew their feelings of confidence and sexuality? How can boomers, who pride themselves on their youthfulness, cope with their body changes and the aches and pains of aging? How can they keep their brains in peak condition and distinguish between forgetfulness and early Alzheimer’s? In roundtable discussions, one-on-one interviews, and video essays, Bob and his guests offer their well-informed, but often conflicting, opinions on how best to live a physically, financially and emotionally fit Life (Part 2).“With the economy’s downturn, baby boomers have been particularly affected – with the shrinking of their life savings, loss of their jobs, and the ageism they confront when looking for a new career,” says Life (Part 2) executive producer Naomi S. Boak, who also produced the critically acclaimed and Emmy Award-winning PBS documentary The Forgetting: A Portrait of Alzheimer’s. “This show is designed to inspire boomers’ own self exploration of how they can make a fresh start at any age… of how they can live 20 or 30 more years of vigor, engagement and impact, defying ageist stereotypes while still having a clear-eyed view of the challenges that come with this new territory.”Robert Lipsyte, host of the PBS series Life (Part 2) and a columnist with USA Today, has been an award-winning sportswriter for The New York Times and was the Emmy-winning host of the PBS public affairs show The Eleventh Hour. He is the author of 16 books including the best-selling young adult novel, The Contender, and the memoir, In the Country of Illness: Comfort and Advice for the Journey.  He is the recipient of the Margaret A. Edwards Award honoring his lifetime contribution in writing for young adults.  Life (Part 2) is produced by Twin Cities Public Television (tpt) and executive produced by Naomi S. Boak and Ron Fried.  About Twin Cities Public Television
Twin Cities Public Television (tpt), the PBS affiliate for Minneapolis/St. Paul, is a prominent producer of national programs for PBS. These programs have been honored with national Emmys, the DuPont-Columbia Commendation, Peabody Awards, an Academy Award nomination and awards at the Chicago, New York, and Tokyo Film Festivals. Their documentary DEPRESSION: Out of the Shadows was a Peabody winner in 2008. In both 2003 and 2004, tpt productions have garnered the national Primetime Emmy for Outstanding Nonfiction Special (Benjamin Franklin and The Forgetting: A Portrait of Alzheimer’s). Award-winning series from tpt include the kids’ science shows DragonflyTV and Newton’s Apple as well as PBS’s cutting-edge arts series, Alive From Off Center.
 Naomi S. Boak, Series Executive Producer
Naomi S. Boak is a senior executive producer in National Productions at tpt. Ms. Boak was the executive producer of the critically acclaimed and primetime Emmy Award-winning The Forgetting: A Portrait of Alzheimer’s, which premiered on PBS in 2004 as well as FAT: What No One Is Telling You, which premiered on PBS in 2007. Boak was the executive producer of Snap Judgment the only daily comedy show on Court TV. She has written and produced Emmy Award-winning primetime children’s specials for CBS and was the executive producer for The Lifetime Medical Television Network.
 Ron Fried, Series Co-Executive Producer
Ron Fried began working in television in 1979 at The Dick Cavett Show, which then aired on PBS, eventually producing Cavett’s CNBC series and has served as producer or executive producer of programs for USA Network, VH1, the History Channel, and others. He spent five years as Vice President and Executive Producer at Cablevision’s MetroTV where his work won five New York Emmy awards. More recently, Fried was Senior Producer for CNBC’s Topic [A] with Tina Brown. He is the author of two novels, My Father’s Fighter and Christmas in Paris, as well as Corner Men: Great Boxing Trainers.
 
Cell phone exposure may protect against and reverse Alzheimer's disease
Friday, 08 January 2010

The USF-led study in mice indicates long-term exposure to electromagnetic waves emitted by cell phones may even boost normal memory

Tampa, FL (Jan. 6, 2010) – The millions of people who spend hours every day on a cell phone, may have a new excuse for yakking. A surprising new study in mice provides the first evidence that long-term exposure to electromagnetic waves associated with cell phone use may actually protect against, and even reverse, Alzheimer’s disease. The study, led by University of South Florida researchers at the Florida Alzheimer’s Disease Research Center (ADRC), was published today in the Journal of Alzheimer’s Disease.

“It surprised us to find that cell phone exposure, begun in early adulthood, protects the memory of mice otherwise destined to develop Alzheimer’s symptoms,” said lead author Gary Arendash, PhD, Research Professor at the Florida ADRC. “It was even more astonishing that the electromagnetic waves generated by cell phones actually reversed memory impairment in old Alzheimer’s mice.”


Can long-term exposure to cell phone signals help treat or prevent dementia and benefit memory? A new USF study concludes it may.

The researchers showed that exposing old Alzheimer’s mice to electromagnetic waves generated by cell phones erased brain deposits of the harmful protein beta-amyloid, in addition to preventing the protein’s build-up in younger Alzheimer’s mice. The sticky brain plaques formed by the abnormal accumulation of beta amyloid are a hallmark of Alzheimer’s disease. Most treatments against Alzheimer’s try to target beta-amyloid.

The highly-controlled study allowed researchers to isolate the effects of cell phone exposure on memory from other lifestyle factors such as diet and exercise. It involved 96 mice, most of which were genetically altered to develop beta-amyloid plaques and memory problems mimicking Alzheimer’s disease as they aged. Some mice were non-demented, without any genetic predisposition for Alzheimer’s, so researchers could test the effects of electromagnetic waves on normal memory as well.

Both the Alzheimer’s and normal mice were exposed to the electromagnetic field generated by standard cell phone use for two 1-hour periods each day for seven to nine months. The mice didn’t wear tiny headsets or have scientists holding cell phones up to their ears; instead, their cages were arranged around a centrally-located antenna generating the cell phone signal. Each animal was housed the same distance from the antenna and exposed to electromagnetic waves typically emitted by a cell phone pressed up against a human head.

The mice were exposed to cell phone signals from a centrally located antenna.

If cell phone exposure was started when the genetically-programmed mice were young adults -- before signs of memory impairment were apparent -- their cognitive ability was protected. In fact, the Alzheimer’s mice performed as well on tests measuring memory and thinking skills as aged mice without dementia. If older Alzheimer’s mice already exhibiting memory problems were exposed to the electromagnetic waves, their memory impairment disappeared. Months of cell phone exposure even boosted the memories of normal mice to above-normal levels. The memory benefits of cell phone exposure took months to show up, suggesting that a similar effect in humans would take years if cell phone-level electromagnetic exposure was provided.

Based on their promising and unexpected findings in mice, the researchers concluded that electromagnetic field exposure could be an effective, non-invasive and drug-free way to prevent and treat Alzheimer’s disease in humans. They are currently evaluating whether different sets of electromagnetic frequencies and strengths will produce more rapid and even greater cognitive benefits than those found in their current study.

“If we can determine the best set of electromagnetic parameters to effectively prevent beta-amyloid aggregation and remove pre-existing beta amyloid deposits from the brain, this technology could be quickly translated to human benefit against AD” said USF’s Chuanhai Cao, PhD, the other major study author. “Since production and aggregation of β-amyloid occurs in traumatic brain injury, particularly in soldiers during war, the therapeutic impact of our findings may extend beyond Alzheimer’s disease.”

The memory test used to evaluate the effects of cell phone exposure in mice was closely designed from a sensitive test used to determine if Alzheimer’s disease, or its very early signs (mild cognitive impairment), are present in humans. “Since we selected electromagnetic parameters that were identical to human cell phone use and tested mice in a task closely analogous to a human memory test, we believe our findings could have considerable relevance to humans,” Arendash said.


The memory and thinking skills of both Alzheimer's mice and normal mice were tested in a specially-designed water maze with visual cues, before and after long-term exposure to cell phone EMF.


The researchers found a slight increase in brain temperature during the two one-hour periods when mice were exposed to electromagnetic waves each day. This increase in brain temperature was seen only in the Alzheimer’s mice, and only after months of exposure. The researchers suggest the increase in brain temperature helped the Alzheimer’s brain to remove newly-formed beta-amyloid by causing brain cells to release it.

The researchers were particularly surprised to discover that months of cell phone exposure actually boosted the memory of non-demented (normal mice) to above-normal levels. They suspect that the main reason for this improvement involves the ability of electromagenetic exposure to increase brain activity, promoting greater blood flow and increased energy metabolism in the brain. “Our study provides evidence that long-term cell phone use is not harmful to brain,” Dr. Cao said. “To the contrary, the electromagnetic waves emitted by cell phones could actually improve normal memory and be an effective therapy against memory impairment”

“It will take some time to determine the exact mechanisms involved in these beneficial memory effects,” Arendash said. “One thing is clear, however - the cognitive benefits of long-term electromagenetic exposure are real, because we saw them in both protection- and treatment-based experiments involving Alzheimer’s mice, as well as in normal mice.”


USF research professor and neuroscientist Gary Arendash, PD, is lead author of the study. "We did not start out the study thinking we'd see these beneficial effects," he said.

Previous human studies of electromagnetic waves from cell phones involved only brief exposures given to normal humans. While some studies reported small improvements in attention or memory (not enough to impact daily life), others reported no memory effects from short-term exposure. The new study by Arendash, Cao, and their colleagues is the first to investigate the effects of long-term electromagnetic exposure over many months on memory function in either humans or animals. The findings indicate that “long-term” exposure to cell phone level electromagnetic waves is needed to observe enhanced memory in normal or memory-impaired mice.

The USF researchers began investigating the effects of cell phone use on Alzheimer’s disease several years ago, after several observational studies in humans linked a possible increased risk of Alzheimer’s with “low-frequency” electromagnetic exposure -- like the energy waves generated by power and telephone lines. However, cell phones emit “high-frequency” electromagnetic waves, which are very different because they can have beneficial effects on brain cell function, such as increasing brain cell activity, Arendash said.

There has been recent controversy about whether electromagnetic waves from cell phones cause brain cancer. Some researchers argue that the risk of glioma (40 percent of all brain tumors) doubles after 10 or more years of cell phone use. However, others argue that since the overall lifetime risk of developing a brain tumor of any type is less than 1 percent, any doubling of this risk would still be very low. Groups such as the World Health Organization, the American Cancer Society, and the National Institutes of Health, have all concluded that scientific evidence to date does not support any adverse health effects associated with the use of cell phones. Consistent with the view of these organizations, th researchers found no autopsy evidence of abnormal growth in brains of the Alzheimer’s mice following many months of exposure to cell phone-level electromagnetic waves. They also found all major peripheral organs, such as the liver and lungs, to be normal.

The research was conducted by an interdisciplinary group of neuroscientists, electrical engineers, and neurologists from universities in Japan and China as well as from the Florida ADRC at the University of South Florida. The studies were supported by funds from the Florida ADRC, a statewide project sponsored by the National Institute on Aging.

Electromagnetic Field Treatment Protects Against and Reverses Cognitive Impairment in Alzheimer’s Disease Mice. Gary W. Arendash, Juan Sanchez-Ramos, Takashi Mori, Malgorzata Mamcarz, Xiaoyang Lin, Melissa Runfeldt, Li Want, Guixin Zhang, Vasyl Sava, Juan Tan and Chuanhai Cao. Journal of Alzheimer’s Disease, Volume 19:1 (January 2010).


- About USF Health –

USF Health (www.health.usf.edu) is dedicated to creating a model of health care based on understanding the full spectrum of health. It includes the University of South Florida’s colleges of medicine, nursing, and public health; the schools of biomedical sciences as well as physical therapy & rehabilitation sciences; and the USF Physicians Group. With more than $380.4 million in research grants and contracts last year, the University of South Florida is one of the nation’s top 63 public research universities and one of only 25 public research universities nationwide with very high research activity that is designated as community-engaged by the Carnegie Foundation for the Advancement of Teaching.


- About the Journal of Alzheimer’s Disease -

The Journal of Alzheimer's Disease (http://www.j-alz.com) is an international multidisciplinary journal to facilitate progress in understanding the etiology, pathogenesis, epidemiology, genetics, behavior, treatment and psychology of Alzheimer's disease. The journal publishes research reports, reviews, short communications, book reviews, and letters-to-the-editor. Groundbreaking research that has appeared in the journal includes novel therapeutic targets, mechanisms of disease and clinical trial outcomes. The Journal of Alzheimer's Disease has an Impact Factor of 5.101 according to Thomson Reuters' 2008 Journal Citation Reports. The Journal is published by IOS Press (http://www.iospress.nl).

  << Start < Prev 1 2 3 4 Next > End >>

Results 1 - 24 of 73

Inside the Brain:
An Interactive Tour

braintour.gif
Courtesy of the:
alzheimers-association.gif
My site was nominated for Best Health Blog! HealthCentral Top Site AwardCFA_logo_winner.jpg
© Copyright 2007 The KnowItAlz Group. Site Map.
RSS Feeds: Entries - News - Comments
Web design by plethoradesign.com